1. CARDIAC REHABILITATION CHAPTER 5 PRESENTATION SAMSON VAS 2. Cardiac rehabilitation aims to reverse limitations experienced by patients who have suffered the adverse pathophysiologic…

SAMPLE SIZE DETERMINATION SAMPLE SIZE DETERMINATION GRAEME HICKEY INSTITUTE OF INFECTION & GLOBAL HEALTH APRIL 24TH INTRODUCTION Want a copy of these slides? Email me:…

Slide 1 Ref. NEJM Vol 360, No 3, pp 213-224. Slides courtesy Nico H J Pijls. The New England Journal of Medicine January 15, 2009. Vol. 360, No.3. pp. 213-224. Nico H.J.Pijls,…

Slide 1 TCT, October 14 th, 2008 Nico H.J.Pijls, MD, PhD Catharina Hospital, Eindhoven The Netherlands, The Netherlands, on behalf of the FAME investigators FRACTIONAL FLOW…

Slide 1 | The WOEST Trial: First randomised trial comparing two regimens with and without aspirin in patients on oral anticoagulant therapy undergoing coronary stenting Willem…

* Oral Cilostazol Prevents Restenosis And Repeat Revascularization After Percutaneous Coronary Stenting: A Meta-Analysis Of 15 Randomized Trials And 4897 Patients G. Biondi-Zoccai,1…

Lessons Learnt from Recent Trials in Ischemic Heart Disease John M. Mandrola1 Sanjay Kaul2 Andrew Foy3 1Department of Cardiology, Baptist Health Louisville, Louisville, Kentucky,

Choosing Wisely® Recommendation Analysis: Prioritizing Opportunities for Reducing Inappropriate CareSarah Jane Reed, MSc and Steven Pearson, MD, MSc INSTITUTE FOR CLINICAL

(ORBITA): a double-blind, randomised controlled trial Rasha Al-Lamee, David Thompson, Hakim-Moulay Dehbi, Sayan Sen, Kare Tang, John Davies, Thomas Keeble, Michael Mielewczik,Raffi

Predictors of adherence to treatment by patients with coronary heart disease after percutaneous coronary interventionOR I G I N A L A R T I C L E Predictors of adherence